Enliven Therapeutics Inc (ELVN)
Stock-Based Compensation
$40.81M
TTM · Period ending: · USD
ELVN Stock-Based Compensation
Latest reported$40.81Mperiod ending
Latest reported$40.81Mperiod ending
ELVN TTM Stock-Based Comp ($899.00K → $40.81M)
TTM stock-based compensation
High-resolution chart · PNG
ELVN stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 40,808,000 | |
| 34,617,000 | |
| 34,019,000 | |
| 27,047,000 | |
| 25,038,000 | |
| 22,458,000 | |
| 20,174,000 | |
| 17,891,000 | |
| 16,116,000 | |
| 15,167,000 | |
| 12,914,000 | |
| 10,593,000 | |
| 8,293,000 | |
| 4,799,000 | |
| 3,191,000 | |
| 2,456,000 | |
| 1,355,000 | |
| 654,000 | |
| 0 | |
| 679,000 | |
| 1,321,000 | |
| 1,871,000 | |
| 2,231,000 | |
| 1,849,000 | |
| 1,517,000 | |
| 1,164,000 | |
| 899,000 |